Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Zhezhu Han"'
Autor:
Bowen Men, Huzhe Cui, Zhezhu Han, Xiuying Jin, Qiang Xu, Yongmin Jin, Zhengri Piao, Songnan Zhang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveThis study aimed to explore the efficacy of transarterial chemoembolization (TACE) combined with microwave ablation (MWA) adjuvant to lenvatinib and anti–PD–1 antibodies for patients with hepatocellular carcinoma (HCC).MethodsA retrospec
Externí odkaz:
https://doaj.org/article/a921620b4de24a71bd52e66d0f5ba322
Autor:
Mingyan Ding, Qiang Xu, Xiuying Jin, Zhezhu Han, Hao Jiang, Honghua Sun, Yongmin Jin, Zhengri Piao, Songnan Zhang
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Exosomes are progressively being detected as an indicator for the diagnosis and prognosis of cancer in clinical settings. Many clinical trials have confirmed the impact of exosomes on tumor growth, particularly in anti-tumor immunity and immunosuppre
Externí odkaz:
https://doaj.org/article/d21e2d3d1ff04ac988de5031d7c0653a
Autor:
Qiang Xu, Xinghe Yan, Zhezhu Han, Xiuying Jin, Yongmin Jin, Honghua Sun, Junhua Liang, Songnan Zhang
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Breast cancer is the most common malignancy and the leading cause of cancer-related deaths in women. Recent studies have investigated the prognostic value of the tumor microenvironment (TME)-related genes in breast cancer. The purpose of this researc
Externí odkaz:
https://doaj.org/article/c254e63de61b4107a81ef93e84c1b2ba
Autor:
Zhezhu Han, Dongxu Kang, Yeonsoo Joo, Jihyun Lee, Geun-Hyeok Oh, Soojin Choi, Suwan Ko, Suyeon Je, Hye Jin Choi, Jae J. Song
Publikováno v:
Experimental and Molecular Medicine, Vol 50, Iss 12, Pp 1-19 (2018)
Cancer: Tipping the signaling balance Reducing the levels of the multifunctional protein transforming growth factor (TGF)-β in cancer cells prevents tumor growth in mice. Previous studies have shown that high levels of TGF-β in cancerous tissue are
Externí odkaz:
https://doaj.org/article/88e935c017ed4a64845a571c7fa1db78
Publikováno v:
Journal of computer assisted tomography.
The aim of the study is to assess the clinical value of the combined computed tomography (CT)/ultrasound (US) guidance in microwave ablation (MWA) for hepatocellular carcinoma (HCC).From July 16, 2016, to June 20, 2021, medical records of 150 HCC pat
Autor:
Jeong A. Hong, Soo Jin Choi, Zhezhu Han, Geun-Hyeok Oh, Yeonsoo Joo, Hye Jin Choi, Ji Hyun Lee, Jae J. Song, Suwan Ko, Rong Xu
Publikováno v:
Experimental and Molecular Medicine, Vol 51, Iss 10, Pp 1-20 (2019)
Experimental & Molecular Medicine
Experimental & Molecular Medicine
When the adenoviral protein E1B55K binds death domain-associated protein (Daxx), the proteasome-dependent degradation of Daxx is initiated, and adenoviral replication is effectively maintained. Here, we show that the cellular levels of Daxx differ be
Autor:
Hye Jin Choi, Soo Jin Choi, Dongxu Kang, Geun-Hyeok Oh, Zhezhu Han, Suwan Ko, Suyeon Je, Jihyun Lee, Jae J. Song, Yeonsoo Joo
Publikováno v:
Experimental and Molecular Medicine, Vol 50, Iss 12, Pp 1-19 (2018)
Experimental & Molecular Medicine
Experimental & Molecular Medicine
Transforming growth factor (TGF)-β signaling is increasingly recognized as a key driver in cancer. In progressive cancer tissues, TGF-β promotes tumor formation, and its increased expression often correlates with cancer malignancy. In this study, w
Publikováno v:
Apoptosis. 21:351-364
In this study, we demonstrated that survivin downregulation with TRAIL expression greatly enhanced the cytotoxic death of pancreatic cancer cells after gemcitabine treatment. Using real-time RT-PCR, we analyzed five survivin shRNAs to identify the be
Autor:
Kexin Yu, Xianchun Zhou, Zhezhu Han, Xianglan Quan, Dongxu Kang, Ying Li, Yongmin Jin, Wenbiao Jin, Shengji Li, Tiefeng Jin, Songnan Zhang
Publikováno v:
Investigación Clínica; 2020, Vol. 61 Issue 3, p1605-1613, 9p
Autor:
Hye Jin Choi, Suyeon Je, So Young Kim, Dongxu Kang, Jae J. Song, Yong sic Hwang, Zhezhu Han, Joo Hang Kim, Sujin Kang
Publikováno v:
Cellular signalling. 27(4)
Gemcitabine has been used most commonly as an anticancer drug to treat advanced pancreatic cancer patients. However, intrinsic or acquired resistance of pancreatic cancer to gemcitabine was also developed, which leads to very low five-year survival r